This award is in commemoration of the European pioneer in cancer research and treatment, founding member and first President of ESMO, Prof. Georges Mathé.
It is presented to an individual internationally recognised for outstanding achievements in the area of Immuno-Oncology.
The ESMO Award for Immuno-Oncology is presented at the annual ESMO Immuno-Oncology Congress and the Award recipient is invited to give a keynote lecture during the Opening Ceremony.
ESMO Award for Immuno-Oncology 2021 recipient
The 2021 ESMO Award for Immuno-oncology will be presented to Wolf Hervé Fridman, Professor Emeritus of Immunology, University of Paris Medical School, Paris, France for his outstanding achievements in immuno-oncology.
He will deliver his award lecture on Wednesday, 8 December 2021, 12:45-13:15 CET at the ESMO Immuno-Oncology Congress 2021.
ESMO Award for Immuno-Oncology 2020 recipient
Jedd D. Wolchok, Chief of the Immuno-Oncology Service and Director of the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, US received the ESMO Award for Immuno-Oncology 2020.
He will deliver his award lecture at the ESMO Immuno-Oncology Congress 2021.
Previous recipients of the ESMO Award for Immuno-Oncology
- Thomas Gajewski (2019)
- Cornelis Melief (2018)
- Laurence Zitvogel (2017)
Georges Mathé was previously commemorated by the Georges Mathé Translational Research Fellowship (2012-2016). As of 2017, the fellowship has been replaced by the ESMO Award for Immuno-Oncology.
Nomination and selection process
The recipient is nominated by the ESMO Immuno-Oncology Congress Scientific Committee based on the following eligibility criteria.
The candidate must:
- be an individual who has made a significant impact in the field of immuno-oncology
- be an oncology professional, medical or clinical oncologist or researcher
- be an ESMO member
The candidate must not:
- be a current member of the ESMO Executive Board, the ESMO Council or the ESMO Nomination Committee, nor have served on these committees within the last two years
- be a past recipient of the ESMO Award for Immuno-Oncology
Chairs of the current Scientific Committee may not be nominated. Members of the Scientific Committee are eligible however they may not nominate themselves. More than one nomination is allowed.
All nominations are evaluated and a final awardee is selected by the Selection Committee: the Scientific Committee Co-Chairs of the ESMO Immuno-Oncology Congress, the ESMO Nomination Committee Chair and the ESMO President.